Dr. David J. Ecker, divisional vice president, R&D, Ibis Biosciences, Abbott, discusses IRIDICA’s ability to detect 1,000s of infection-causing pathogens more quickly than the current standard of care of culture
Jean-Louis Vincent, professor of Intensive Care Medicine, Université Libre de Bruxelles, Belgium, shares the need to diagnose infections quickly, so doctors can start treating those who are critically ill with appropriate therapies sooner